Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
Revista
País de afiliação
Intervalo de ano de publicação
1.
Elife ; 82019 06 24.
Artigo em Inglês | MEDLINE | ID: mdl-31232688

RESUMO

Parasitic helminths infect over a billion humans. To survive in the low oxygen environment of their hosts, these parasites use unusual anaerobic metabolism - this requires rhodoquinone (RQ), an electron carrier that is made by very few animal species. Crucially RQ is not made or used by any parasitic hosts and RQ synthesis is thus an ideal target for anthelmintics. However, little is known about how RQ is made and no drugs are known to block RQ synthesis. C. elegans makes RQ and can use RQ-dependent metabolic pathways - here, we use C. elegans genetics to show that tryptophan degradation via the kynurenine pathway is required to generate the key amine-containing precursors for RQ synthesis. We show that C. elegans requires RQ for survival in hypoxic conditions and, finally, we establish a high throughput assay for drugs that block RQ-dependent metabolism. This may drive the development of a new class of anthelmintic drugs. This study is a key first step in understanding how RQ is made in parasitic helminths.


Assuntos
Caenorhabditis elegans/metabolismo , Cinurenina/metabolismo , Redes e Vias Metabólicas/genética , Ubiquinona/análogos & derivados , Anaerobiose , Animais , Caenorhabditis elegans/genética , Hipóxia , Análise de Sobrevida , Ubiquinona/biossíntese
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA